hCG dosage: reported doses and schedule
A fertility hormone with limited testosterone add-on evidence and no proven weight-loss benefit.
Also called: human chorionic gonadotropin, human chorionic gonadotrophin, chorionic gonadotropin, choriogonadotropin alfa, Pregnyl, Novarel, Ovidrel, Ovitrelle.
Reproductive axis peptides · LH/chorionic gonadotropin receptor agonist; glycoprotein hormone · Evidence: Approved drug.
Typical reported dose: 500–1000 units three times a week, then twice a week
- Male hypogonadotropism: six-week schedule: 500 to 1000 USP units 3 times a week for 3 weeks, then the same dose twice a week for 3 weeks three times weekly, then twice weekly, into muscle. Drug label. Studied in: Selected cases of male hypogonadotropic hypogonadism. (source)
- Male hypogonadotropism: longer course: 4000 USP units 3 times weekly for 6 to 9 months; may be reduced to 2000 USP units 3 times weekly for an additional 3 months three times weekly, into muscle. Drug label. Studied in: Selected cases of male hypogonadotropic hypogonadism. (source)
- Urinary hCG: ovulation trigger: 5000 to 10,000 USP units 1 day following the last dose of gonadotropins single trigger dose, into muscle. Drug label. Studied in: Appropriately stimulated infertile women without primary ovarian failure. (source)
- Ovidrel: 250 mcg trigger: 250 mcg one day following the last dose of the follicle stimulating agent single trigger dose, under the skin. Drug label. Studied in: Women undergoing assisted reproduction or ovulation induction. (source)
- Ovitrelle: 24–48-hour trigger: 250 mcg 24 to 48 hours after the last FSH or hMG dose single trigger dose, under the skin. Drug label. Studied in: Women after optimal follicular stimulation. (source)
- TRT study: 125 IU every other day: 125 IU every other day every other day, under the skin. Studied in a trial. Studied in: Healthy men also receiving testosterone enanthate 200 mg IM weekly. (source)
These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.
Related to hCG
- Kisspeptin-10: A short-acting experimental peptide that triggers reproductive hormone release.
- Gonadorelin: A short-acting fertility hormone used in tests and specialist pump therapy.
Sources
- Compounding and the FDA: Questions and Answers, FDA · FDA · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- NOVAREL- gonadotrophin, chorionic kit, Ferring · 2025
- Ovitrelle, European Medicines Agency · 2025
- Ovitrelle, INN-choriogonadotropin alfa, European Medicines Agency · 2025
- Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; Amended 2024), AUA/ASRM · 2024
- OVIDREL- choriogonadotropin alfa injection, solution, EMD Serono · 2023
- Notice to Compounders: Changes that affect compounding as of March 23, 2020, FDA · 2020
- Avoid Dangerous HCG Diet Products, FDA
- Ovitrelle 250 micrograms/0.5 mL solution for injection in pre-filled syringe, Merck
- PREGNYL- choriogonadotropin alfa kit, Organon
- Product information, Health Canada
- Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study., Clift AK et al. · The world journal of men's health · 2026
- Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men., Clift AK et al. · The world journal of men's health · 2026
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.